I-BEIJING SUCCEEDER TECHNOLOGY INC.

Labo abathatha imithi yokunciphisa igazi kufanele baqaphele lapho bedla ubhanana. I-Beijing Succeeder isiza ekuxilongweni kwe-thrombosis kanye ne-hemostasis.

Ubhanana uvame ukubhekwa njengesithelo esinempilo ngenxa yokuqukethwe kwawo okucebile kokudla okunomsoco, okuhlanganisa amavithamini namaminerali. Kodwa-ke, kulabo abathatha imithi yokunciphisa igazi, ubhanana ungaba yingozi empilweni efihliwe.

Izinto zokunciphisa igazi, njenge-warfarin evamile, zisetshenziswa kakhulu ukuvimbela nokwelapha izifo ze-thrombotic. Iziguli ezinezimo ezifana nokuhlinzwa kokushintsha i-valve yenhliziyo, i-atrial fibrillation, kanye ne-venous thrombosis yemilenze engezansi zivame ukudinga ukusetshenziswa isikhathi eside. Indlela yazo yokusebenza ukuvimbela ukusebenza kwezinto zokunciphisa igazi ezincike ku-vitamin K, ngaleyo ndlela kuncishiswe ingozi yokujiya kwegazi futhi kuqinisekiswe ukujikeleza kwegazi okubushelelezi. Ubhanana uyisithelo esicebile nge-vitamin K, cishe ama-microgram ayi-10 ngamagremu ayi-100. I-Vitamin K isebenza "njengesiqalisi" sohlelo lokujiya kwegazi, ikhuthaza ukusebenza kwezinto zokunciphisa igazi futhi isheshise ukujiya kwegazi. Lapho iziguli ezithatha izinto zokunciphisa igazi zidla ubhanana omningi, amazinga azo e-vitamin K anda kakhulu. Lokhu kungamelana nemiphumela yemithi, kunciphise ukusebenza kahle kwento yokunciphisa igazi futhi kwandise kakhulu ingozi yokujiya kwegazi. Isiguli esinomfutho wegazi ophakeme esasithatha i-warfarin iminyaka emithathu sathola izimpawu zokunciphisa igazi ezingalawuleki ngemuva kokudla i-banana smoothie nesidlo sasekuseni isonto lonke, ekugcineni kwaholela ekulalisweni esibhedlela ngenxa yesifo sohlangothi. Leli cala lisebenza njengesibonakaliso sokuvuka kweziguli ezithatha izinto zokunciphisa igazi.

Kodwa-ke, lokhu akusho ukuthi abantu abathatha imithi yokunciphisa igazi kufanele bagweme ngokuphelele ubhanana. Ngokusho kwe-"Dietary Guidelines for Chinese Residents (2022), abantu abadala kufanele badle amagremu angu-200-350 ezithelo nsuku zonke, okulingana cishe nobhanana owodwa kuya kwamabili. Ukusetshenziswa okulingene ngokuvamile akuthinti kakhulu ukusebenza kahle kwemithi yokunciphisa igazi. Kodwa-ke, isihluthulelo ukugcina ukudla okulinganiselayo nokuzinzile nokugwema ukushintshashintsha okukhulu kokudla kwe-vitamin K ngezikhathi ezimfushane.

I-Beijing Succeeder Technology Inc. (ikhodi yesitoko: 688338) ingumholi emkhakheni wokuxilongwa kwe-thrombosis kanye ne-hemostasis ngaphakathi kwe-vitro. Yasungulwa ngo-2003, inkampani iminyaka eminingi igxile ocwaningweni, ekuthuthukisweni, ekukhiqizweni, nasekuthengisweni kwezinsimbi zokuxilonga kanye nama-reagents okuxilonga kanye ne-hemostasis ngaphakathi kwe-vitro. I-Beijing Succeeder inikeza izikhungo zezokwelapha izinsimbi zokuhlola ezenzakalelayo, okuhlanganisa ukujiya kwegazi, i-hemorheology, i-hematocrit, kanye nokuhlanganiswa kwama-platelet, kanye nokusekela ama-reagents kanye nezinto ezisetshenziswayo. Imikhiqizo yayo isetshenziswa kabanzi ekuvimbeleni, ekuhloleni, ekuxilongeni, nasekuqapheni izifo ze-thrombotic kanye ne-hemorrhagic, okuhlanganisa isifo sohlangothi, isifo semithambo yenhliziyo, kanye ne-venous thromboembolism.

Ngo-2023, i-Beijing Succeeder's fully automated coagulation analyzer yathola ukubhaliswa kwe-IVDR CE, yaqhubeka nokukhombisa amandla ayo obuchwepheshe kanye nekhwalithi yomkhiqizo emkhakheni wokuxilonga we-in vitro. Idatha ekhishwe ngo-Agasti 17 walowo nyaka ibonise ukuthi inkampani ithole imali engenayo yokusebenza eyizigidi eziyi-141 zama-yuan engxenyeni yokuqala yonyaka, ukwanda konyaka nonyaka okungu-33.19%, kanye nenzuzo ehlanganisiwe ebangelwa abanikazi bamasheya abayizigidi ezingama-60.222 zama-yuan, ukwanda konyaka nonyaka okungu-26.91%. Ngaphezu kwalokho, iBeijing Succeeder ithole izindondo eziningi, okuhlanganisa nokukhethwa ohlwini lwe-National Torch Program Key High-Tech Enterprise List luka-2012 olushicilelwe yi-Torch Center yoMnyango Wezesayensi Nobuchwepheshe, kanye nokubekwa endaweni yama-29 ku-2022 China In Vitro Diagnostic Industry Listed Company Net Profit Ranking.

I-Beijing Succeeder, ngemikhiqizo yayo yobungcweti kanye nobuchwepheshe, inikeza ukwesekwa okuqinile kodokotela ukuze bahlole ngokunembile isimo sokujiya kweziguli, idlala indima ebalulekile ekuvikeleni impilo yeziguli. Ezigulini ezithatha imithi yokunciphisa igazi, ukuqapha njalo ngobuchwepheshe bokuhlola obuthuthukisiwe kanye nemikhiqizo, ngenkathi kuqashelwa ukusebenzisana kokudla kanye nemithi, kungaqinisekisa kangcono ukusebenza kahle kokwelashwa kanye nempilo iyonke.